Expertise in
12
conditions

Dr. Irene A. Dy

Hematology
MultiCare Deaconess Medical Office Building 1
910 W 5th Ave, 
Spokane, WA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
12
conditions
MultiCare Deaconess Medical Office Building 1
910 W 5th Ave, 
Spokane, WA 

Overview

Irene Dy is a Hematologist practicing medicine in Spokane, Washington.

Dr. Dy is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Thrombocytopenia, Essential Thrombocythemia, and Non-Hodgkin Lymphoma.

She is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 6 clinical trials. Dr. Dy is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in CA

Hospital Affiliations

Stanford Health Care Tri-Valley
Good Shepherd Medical Center
Deaconess Medical Center
Prosser Memorial Hospital
Kadlec Regional Medical Center

Languages Spoken

English
Castilian
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Inland Empire Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

MultiCare Deaconess Medical Office Building 1
910 W 5th Ave, Spokane, WA 99204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
Enrollment Status: Recruiting
Publish Date: May 18, 2026
Intervention Type: Drug
Study Drug: Screening Platform
Study Phase: Phase 2/Phase 3
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Other
Study Phase: Phase 3
Randomized Phase II Clinical Trial of Cisplatin/Carboplatin and Etoposide (CE) Alone or in Combination With Nivolumab as Frontline Therapy for Extensive Stage Small Cell Lung Cancer (ED-SCLC)
Randomized Phase II Clinical Trial of Cisplatin/Carboplatin and Etoposide (CE) Alone or in Combination With Nivolumab as Frontline Therapy for Extensive Stage Small Cell Lung Cancer (ED-SCLC)
Enrollment Status: Completed
Publish Date: July 03, 2025
Intervention Type: Drug, Biological
Study Drugs: Carboplatin, Cisplatin, Etoposide, Nivolumab
Study Phase: Phase 2
A Phase II Study of Rucaparib in Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)
A Phase II Study of Rucaparib in Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)
Enrollment Status: Completed
Publish Date: May 21, 2025
Intervention Type: Drug
Study Drug: Rucaparib
Study Phase: Phase 2
A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug, Biological
Study Drugs: Docetaxel, Gemcitabine, Gemcitabine Hydrochloride, Pembrolizumab, Pemetrexed, Pemetrexed Disodium, Ramucirumab
Study Phase: Phase 2
Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
Enrollment Status: Terminated
Publish Date: July 27, 2022
Intervention Type: Drug, Other
Study Drug: Varenicline
Study Phase: Phase 3
View 5 Less Clinical Trials

4 Total Publications

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108).
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 07, 2022
Similar Doctors
Expertise in
34
conditions
Dr. Saritha C. Thumma
Hematology | Oncology
Expertise in
34
conditions
Dr. Saritha C. Thumma
Hematology | Oncology
Referral may be required
Before you request
601 South Sherman Street, 
Spokane, WA 
 (2.2 miles away)
509-228-1000
Languages Spoken:
English, Afrikaans, German, Hindi, Japanese, Malay, Mandarin, Polish, Spanish, Tamil, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Saritha Thumma is a Hematologist and an Oncologist practicing medicine in Spokane, Washington. Dr. Thumma is highly rated in 34 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Thumma is currently accepting new patients.

Expertise in
39
conditions
Dr. Hakan Kaya
Hematology
Expertise in
39
conditions
Dr. Hakan Kaya
Hematology
Referral may be required
Before you request
601 South Sherman Street, 
Spokane, WA 
 (2.2 miles away)
509-228-1000
Languages Spoken:
English, Hindi, Korean, Mandarin, Punjabi, Romanian, Spanish, Turkish
See accepted insurances
Accepting New Patients
Offers Telehealth

Hakan Kaya is a Hematologist practicing medicine in Spokane, Washington. Dr. Kaya is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Kaya is currently accepting new patients.

Expertise in
39
conditions
Dr. Srivalli Gopaluni
Hematology | Oncology
Expertise in
39
conditions
Dr. Srivalli Gopaluni
Hematology | Oncology
Referral may be required
Before you request
605 East Holland Avenue, 
Spokane, WA 
 (7.4 miles away)
509-228-1000
Languages Spoken:
English, Afrikaans, Hindi, Spanish, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Srivalli Gopaluni is a Hematologist and an Oncologist practicing medicine in Spokane, Washington. Dr. Gopaluni is highly rated in 39 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Familial Colorectal Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Gopaluni is currently accepting new patients.

Frequently Asked Questions about Dr. Irene A. Dy

How do I make an appointment with Dr. Irene A. Dy?

You can book an appointment with Dr. Irene A. Dy by calling their office at 509-473-5800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Irene A. Dy a top-rated expert for Myelodysplastic Syndrome (MDS)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Irene A. Dy is classified as an Advanced expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Irene A. Dy specialize in?

While Dr. Irene A. Dy is a Hematology, they have specific expertise in Myelodysplastic Syndrome (MDS), Thrombocytopenia, and Essential Thrombocythemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Irene A. Dy participate in research or clinical trials?

Yes. Dr. Irene A. Dy has published 4 articles and abstracts on conditions like Myelodysplastic Syndrome (MDS). You can view a list of Dr. Irene A. Dy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Irene A. Dy accept my insurance?

Dr. Irene A. Dy accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 509-473-5800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dy's expertise for a condition
ConditionClose
      View All 12 Advanced Conditions
      View All 52 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile